Trevi Therapeutics (TRVI) has successfully completed the End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA).

老虎证券2026/03/09 11:45

Show original

Both parties have reached an important consensus regarding the company's research and development plan for chronic cough associated with idiopathic pulmonary fibrosis, laying a solid foundation for the subsequent clinical development pathway.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops

Lock your assets and earn 10%+ APR

Lock now!

A senior official from the U.S. Department of Justice recently stated that ticketing giant Ticketmaster and its parent company Live Nation Entertainment will be prohibited from interfering with the freedom of venue selection in the primary ticketing market through pricing strategies, technological barriers, or any other means.

老虎证券•2026/03/09 14:24

The CEO of Embraer recently revealed that the company may roll out E175 jets from its assembly line in India as early as 2028.

老虎证券•2026/03/09 14:20

Trevi Therapeutics (TRVI) has successfully completed the End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA).

You may also like

Trending news

Crypto prices